Results
2694
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
2,694 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
JNJ | US$146.82 | -0.1% | -7.9% | US$353.5b | US$167.52 | PE25.1x | E8.4% | 3.4% | Pharmaceuticals & Biotech | ||
AZN | UK£111.80 | 3.6% | 5.8% | UK£171.3b | UK£138.00 | PE33.4x | E17.0% | 2.0% | Pharmaceuticals & Biotech | ||
HSBA | UK£8.25 | -0.1% | 33.6% | UK£143.6b | UK£8.67 | PB0.9x | E-1.3% | 5.9% | Banks | ||
CBA | AU$158.65 | 3.1% | 38.1% | AU$265.3b | AU$100.40 | PB3.6x | E4.4% | 2.9% | Banks | ||
LOW | US$262.20 | 0.4% | 23.8% | US$148.1b | US$282.24 | PE21.7x | E5.9% | 1.8% | Retail | ||
PFE | US$26.09 | -0.8% | -5.1% | US$147.9b | US$31.18 | PE34.6x | E8.5% | 6.6% | Pharmaceuticals & Biotech | ||
COP | US$101.83 | -3.8% | -8.8% | US$131.7b | US$132.59 | PE13.3x | E1.8% | 3.7% | Energy | ||
BHP | AU$39.31 | -1.8% | -17.3% | AU$199.4b | AU$44.32 | PE15.9x | E6.4% | 5.9% | Materials | ||
TD | CA$82.15 | -0.3% | -0.8% | CA$143.8b | CA$85.86 | PB1.3x | E10.8% | 5.1% | Banks | ||
INVE A | SEK 310.00 | -0.4% | 27.7% | SEK 964.5b | SEK 331.50 | PE8.4x | E-48.3% | 1.7% | Diversified Financials | ||
ATCO A | SEK 186.90 | 0.6% | 12.7% | SEK 907.8b | SEK 191.09 | PE31.7x | E7.9% | 1.5% | Capital Goods | ||
BP. | UK£4.17 | -3.0% | -10.5% | UK£66.1b | UK£4.77 | PE30.1x | E23.6% | 5.9% | Energy | ||
BREN | Rp9,600.00 | -2.3% | 84.6% | Rp1284.3t | n/a | PE728.4x | n/a | 0.04% | Utilities | ||
ITW | US$259.90 | 1.4% | -1.6% | US$76.7b | US$264.31 | PE22.2x | E1.1% | 2.3% | Capital Goods | ||
NAB | AU$39.40 | 4.3% | 23.9% | AU$120.8b | AU$33.88 | PB2x | E2.0% | 4.3% | Banks | ||
1299 | HK$53.75 | -2.0% | -17.1% | HK$575.2b | HK$93.02 | PE15.3x | E13.7% | 3.0% | Insurance | ||
WBC | AU$33.02 | 2.7% | 39.3% | AU$113.2b | AU$28.53 | PB1.6x | E-0.04% | 4.6% | Banks | ||
DGE | UK£24.94 | 2.3% | -12.2% | UK£55.6b | UK£26.41 | PE17.9x | E5.0% | 3.3% | Food, Beverage & Tobacco | ||
GSK | UK£14.02 | 3.5% | -8.6% | UK£55.4b | UK£17.94 | PE22.8x | E20.8% | 4.1% | Pharmaceuticals & Biotech | ||
CRH | US$101.26 | 3.6% | 43.2% | US$68.6b | US$113.54 | PE19.9x | E9.5% | 1.4% | Materials | ||
KMI | US$30.27 | -0.1% | 74.3% | US$67.2b | US$29.42 | PE25.7x | E11.3% | 3.8% | Energy | ||
CNR | CA$151.40 | 2.1% | -9.1% | CA$95.2b | CA$171.24 | PE17.5x | E3.9% | 2.2% | Transportation | ||
FDX | US$273.29 | -0.7% | 10.2% | US$65.8b | US$323.52 | PE17x | E12.9% | 2.0% | Transportation | ||
SPG | US$174.25 | 0.06% | 22.9% | US$65.4b | US$186.53 | PB21.3x | E0.4% | 4.8% | Real Estate |